News AliveCor and Mayo Clinic collaborate on heart screening tech New tool will help screen for Long QT syndrome to prevent sudden deaths.
Views & Analysis The Virtual Valve: improving treatment decisions for aortic ... How can a virtual reality heart aid in the treatment of a common heart condition?
News Novo's Saxenda label to include cardio data Label will reflect heart benefit seen in LEADER trial.
News Novartis' canakinumab cuts risk for heart attack survivors Novartis to discuss canakinumab results with regulators.
News J&J diabetes drug hit by amputation risk Invokana produces modest CV benefit, but doubles risk of amputation
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.